Company Analysis

Pulmatrix, Inc. (PULM)

Nasdaq: PULM · Pharmaceutical Preparations · Framingham, MA · filing with the SEC since 2013
Grade6.3
◀ Past 5.8● Present 5.8▶ Future 7.0
3 est.

Who owns Pulmatrix, Inc.

As filed with the SEC
Holders of 5% or more
1
RCM Eos PIPE HOLDINGS, LLC holds 9.99% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D filed Apr 22, 2026 says.
Directors and officers
0
report now, of 20 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
RCM Eos PIPE HOLDINGS, LLC
SCHEDULE 13D · filed Apr 22, 2026 · Common Stock, par value $0.0001 per share
9.99%
What PULM reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Cipla Technologies LLC
An entity · legal entity · owns, named in the 10-K/A filed Jun 16, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2018 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton PULM · research, not advice